Cardiovascular Events in Type-2-Diabetes: Insulin Degludec vs. Glargine

被引：0
|
作者：
Lichert, Frank
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1642 / +
页数：2
相关论文
共 50 条
  • [1] Cardiovascular Events in Type 2 Diabetes: Insulin Degludec vs. Glargine
    Lichert, Frank
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (06) : 433 - 433
  • [2] Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) DEVOTE 1
    Marso, Steven P.
    McGuire, Darren K.
    Zinman, Bernard
    Poulter, Neil R.
    Emerson, Scott S.
    Pieber, Thomas R.
    Pratley, Richard E.
    Haahr, Poul-Martin
    Lange, Martin
    Frandsen, Kirstine Brown
    Rabol, Rasmus
    Buse, John B.
    [J]. AMERICAN HEART JOURNAL, 2016, 179 : 175 - 183
  • [3] Insulin Degludec Reduces Hypoglycemia and Improves Health Status vs. Insulin Glargine in Insulin-Naive Type 2 Diabetes
    Rodbard, Helena W.
    Handelsman, Yehuda
    Cariou, Bertrand
    Johansen, Thue
    Christensen, Torsten E.
    Mathieu, Chantal
    [J]. DIABETES, 2012, 61 : A307 - A308
  • [4] Insulin degludec vs. Insulin glargine 100 U/ml in diabetes: 2-year results
    Siegmund, T.
    Westrup, D.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (01): : 21 - 28
  • [5] Health Status in People With Type 2 Diabetes on Basal-Oral Therapy is Significantly Improved With Insulin Degludec vs. Insulin Glargine
    Freemantle, Nick
    Meneghini, Luigi
    Christensen, Torsten E.
    Wolden, Michael
    Jendle, Johan
    Ratner, Robert E.
    [J]. DIABETES, 2012, 61 : A313 - A313
  • [6] Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
    Marc Evans
    Roopa Mehta
    Jens Gundgaard
    Barrie Chubb
    [J]. Diabetes Therapy, 2018, 9 : 1919 - 1930
  • [7] Reduced nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a two year trial in Type 2 diabetes
    Cariou, B.
    Rodbard, H.
    Zinman, B.
    Philis-Tsimikas, A.
    Handlesman, Y.
    Skoth, T. V.
    Chu, P-L
    Mathieu, C.
    [J]. DIABETIC MEDICINE, 2013, 30 : 55 - 55
  • [8] Type 2 Diabetes: Direct Comparison between Insulin Glargine and Insulin Degludec
    Lichert, Frank
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (06) : 546 - 546
  • [9] Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
    Evans, Marc
    Mehta, Roopa
    Gundgaard, Jens
    Chubb, Barrie
    [J]. DIABETES THERAPY, 2018, 9 (05) : 1919 - 1930
  • [10] Insulin glargine 300 E/ml - Efficacy and Safety of fixed vs. flexible Injection Intervals in Patients with Type-2-Diabetes
    Becker, R.
    Jeandidier, N.
    Riddle, M.
    Bolli, G.
    Home, P.
    Bergenstal, R.
    Ziemen, M.
    Muehlen-Bartmer, I.
    Wardecki, M.
    Vinet, L.
    Yki-Jarvinen, H.
    [J]. INTERNIST, 2015, 56 : 14 - 15
12345